Created in 1983 (Belgium), GYNO-FUNGISTAT own 2466 sister brands and 17477 competing brands. GYNO-FUNGISTAT is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York GYNO-FUNGISTAT belongs to the Drug Manufacturers business sector.

GYNO-FUNGISTAT is a brand of JOHNSON & JOHNSON (JNJ) Share price

International deposit : 1983 Business sector Drug Manufacturers

Share price and profitability of the share JOHNSON & JOHNSON (GYNO-FUNGISTAT)

Buy JOHNSON & JOHNSON share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 146.82

Portfolio valuation
JOHNSON & JOHNSON (GYNO-FUNGISTAT) over 5 years* USD 152.22

Stock market history JOHNSON & JOHNSON (GYNO-FUNGISTAT)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
JOHNSON & JOHNSON

OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
ZARBEE'S
ZARBEE'S
SUDAFED
SUDAFED
See more brands of JOHNSON & JOHNSON

Rival brands
GYNO-FUNGISTAT

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
CARMOT THERAPEUTICS
CARMOT THERAPEUTICS
Globion
Globion
Telavant
Telavant
Tepezza
Tepezza
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS